Solana Company (HSDT)
Official siteFINANCIAL SERVICES • MEDICAL DEVICES • NASDAQ
Market Cap: $108.79M
Last updated: Nov 17, 2026 at 11:06 AM ET
Solana Company (HSDT) Financials: Revenue, Profit and Cash Flow
Solana Company reported revenue of $6.02M for the fiscal year ended Dec 31, 2025, up 1057.1% from the year before. That year, net income was -$40.89M with a net margin of -679.6%, operating cash flow was -$16.51M and free cash flow was -$16.51M. The quarter ended Sep 30, 2026 had revenue of $3.36M and net income of $105.16M.
Revenue and Margins
Over the 7 years to Dec 2025, revenue grew from $478.00K, a compound annual rate of 43.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $6.02M | +1057.1% | 91.7% | -4052.5% | -679.6% |
| Dec 2024 | $520.00K | -19.3% | -11.9% | -2673.7% | -2258.1% |
| Dec 2023 | $644.00K | -18.2% | 9.5% | -1929.8% | -1374.2% |
| Dec 2022 | $787.00K | +50.8% | 41.2% | -1971.5% | -1788.1% |
| Dec 2021 | $522.00K | -21.0% | 42.9% | -3475.5% | -3473.6% |
| Dec 2020 | $661.00K | -55.8% | 41.3% | -2176.4% | -2137.7% |
| Dec 2019 | $1.50M | +213.0% | 43.4% | -1604.0% | -653.8% |
| Dec 2018 | $478.00K | N/A | 100.0% | -5580.5% | -5988.1% |
| Dec 2017 | $0 | N/A | N/A | N/A | N/A |
| Dec 2016 | $0 | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.02M | $520.00K | $644.00K | $787.00K | $522.00K | $661.00K | $1.50M | $478.00K | $0 | $0 |
| Cost of revenue | $500.00K | $582.00K | $583.00K | $463.00K | $298.00K | $388.00K | $846.00K | $0 | $0 | $0 |
| Gross profit | $5.52M | -$62.00K | $61.00K | $324.00K | $224.00K | $273.00K | $650.00K | $478.00K | $0 | $0 |
| Research and development | $3.51M | $3.66M | $2.94M | $4.26M | $5.99M | $4.58M | $8.06M | $9.94M | $14.39M | $3.65M |
| Operating income | -$243.84M | -$13.90M | -$12.43M | -$15.52M | -$18.14M | -$14.39M | -$24.00M | -$26.68M | -$22.85M | -$9.32M |
| Net income | -$40.89M | -$11.74M | -$8.85M | -$14.07M | -$18.13M | -$14.13M | -$9.78M | -$28.62M | -$28.02M | -$6.88M |
| EBITDA | $155.61M | -$11.72M | -$8.95M | -$12.98M | -$17.82M | -$13.65M | -$9.59M | N/A | N/A | -$6.83M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.36M | $2.53M | $3.62M | $5.23M | $697.00K | $43.00K | $49.00K | $152.00K | $51.00K | $182.00K | $135.00K | $134.00K |
| Gross profit | $2.74M | $2.45M | $3.44M | $5.05M | $594.00K | -$53.00K | -$72.00K | -$2.00K | -$136.00K | $64.00K | $12.00K | $44.00K |
| Operating income | $103.85M | -$32.67M | -$99.62M | -$201.06M | -$35.45M | -$3.32M | -$4.01M | -$3.15M | -$4.07M | -$3.27M | -$3.42M | -$2.25M |
| Net income | $105.16M | -$30.26M | -$99.80M | $325.55M | -$352.77M | -$9.83M | -$3.84M | -$3.93M | -$3.69M | -$1.61M | -$2.52M | -$1.04M |
Balance Sheet
As of Dec 2025, cash and equivalents of $7.28M were 2.4% of total assets of $303.93M, against total liabilities of $3.02M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $303.93M | $3.54M | $7.69M | $17.29M | $14.10M | $6.55M | $10.35M | $27.83M | $6.81M | $3.45M |
| Current assets | $31.16M | $3.42M | $7.44M | $16.70M | $12.59M | $4.68M | $7.24M | $26.96M | $6.62M | $3.45M |
| Cash and equivalents | $7.28M | $1.09M | $5.18M | $14.55M | $11.01M | $3.33M | $5.46M | $25.58M | $5.56M | $2.67M |
| Total liabilities | $3.02M | $2.48M | $5.34M | $9.14M | $2.85M | $2.68M | $4.51M | $17.97M | $14.30M | $6.89M |
| Short-term debt | N/A | $12.00K | $45.00K | $54.00K | $3.00K | $59.00K | $172.00K | $13.77M | $1.01M | $4.47M |
| Shareholder equity | $300.91M | $1.06M | $2.35M | $8.15M | $11.26M | $3.87M | $5.83M | $9.85M | -$7.49M | -$3.44M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $292.65M | $176.05M | $200.71M | $303.93M | $475.92M | $7.89M | $3.48M | $3.54M | $5.58M | $8.85M | $5.76M | $7.69M |
| Total liabilities | $19.08M | $6.37M | $2.81M | $3.02M | $628.31M | $1.87M | $2.20M | $2.48M | $1.79M | $2.51M | $3.77M | $5.34M |
| Cash and equivalents | $1.13M | $3.65M | $4.39M | $7.28M | $124.05M | $6.08M | $1.11M | $1.09M | $3.47M | $6.39M | $3.64M | $5.18M |
| Shareholder equity | $266.24M | $165.65M | $197.90M | $300.91M | -$152.39M | $6.03M | $1.28M | $1.06M | $3.80M | $6.34M | $1.99M | $2.35M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$16.51M | -$11.04M | -$10.42M | -$14.31M | -$13.39M | -$11.74M | -$21.00M | -$19.62M | -$19.32M | -$7.94M |
| Capital expenditures | $0 | $5.00K | $29.00K | $17.00K | $56.00K | $70.00K | $353.00K | $440.00K | $190.00K | $7.94M |
| Free cash flow | -$16.51M | -$11.05M | -$10.45M | -$14.33M | -$13.44M | -$11.81M | -$21.35M | -$20.06M | -$19.52M | -$15.87M |
| Share repurchases | $17.11M | $1.00M | $65.00K | $775.00K | $2.89M | $1.01M | $247.00K | $3.16M | $1.25M | N/A |
| Investing cash flow | -$426.53M | -$5.00K | -$29.00K | -$11.00K | -$56.00K | -$9.00K | -$769.00K | -$440.00K | -$190.00K | $378.00K |
| Financing cash flow | $449.24M | $6.95M | $1.08M | $17.87M | $21.13M | $9.64M | $1.65M | $40.03M | $22.22M | $9.69M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.07M | -$11.89M | -$4.83M | -$6.18M | -$4.04M | -$2.76M | -$3.54M | -$2.38M | -$2.77M | -$2.89M | -$3.00M | -$2.03M |
| Capital expenditures | N/A | N/A | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5.00K | $3.00K |
| Free cash flow | N/A | N/A | -$4.83M | -$6.18M | -$4.04M | -$2.76M | -$3.54M | -$2.38M | -$2.77M | -$2.89M | -$3.01M | -$2.04M |
Frequently Asked Questions About HSDT
What is Solana Company's annual revenue?
Solana Company reported revenue of $6.02M for the fiscal year ended Dec 31, 2025.
How fast is Solana Company's revenue growing?
Revenue was up 1057.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 97.0%.
Is Solana Company profitable?
No. Solana Company reported net income of -$40.89M for the fiscal year ended Dec 31, 2025, with a net margin of -679.6%.
How much free cash flow does HSDT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$16.51M minus capital expenditures of $0 produced free cash flow of -$16.51M.
How much debt does Solana Company have?
The balance sheet dated Dec 31, 2025 reported cash and equivalents of $7.28M.
HSDT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors